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Abstract
: The presence of an extra sex chromosome is associatedBackground
with an increased rate of neurodevelopmental difficulties involving
language. The 'double hit' hypothesis proposes that the adverse impact of
the extra sex chromosome is amplified when genes that are expressed
from the sex chromosomes interact with autosomal variants that usually
have only mild effects. We predicted that the impact of an additional sex
chromosome on neurodevelopment would depend on common autosomal
variants involved in synaptic functions.
   We analysed data from 130 children with sex chromosomeMethods:
trisomies (SCTs: 42 girls with trisomy X, 43 boys with Klinefelter syndrome,
and 45 boys with XYY). Two comparison groups were formed from 370
children from a twin study. Three indicators of phenotype were: (i) Standard
score on a test of nonword repetition; (ii). A language factor score derived
from a test battery; (iii) A general scale of neurodevelopmental challenges
based on all available information. Preselected regions of two genes, 
 and  , were tested for association withCNTNAP2 NRXN1
neurodevelopmental outcomes using Generalised Structural Component
Analysis.
 There was wide phenotypic variation in the SCT group, as well asResults:
overall impairment on all three phenotypic measures. There was no
association of phenotype with   or  variants in either theCNTNAP2 NRXN1 
SCT group or the comparison groups. Supplementary analyses found no
indication of any impact of trisomy type on the results, and exploratory
analyses of individual SNPs confirmed the lack of association.
We cannot rule out that a double hit may be implicated in theConclusions: 
phenotypic variability in children with SCTs, but our analysis does not find
any support for the idea that common variants in   or  areCNTNAP2 NRXN1 
associated with the severity of language and neurodevelopmental
impairments that often accompany an extra X or Y chromosome.
 Stage 1 report: http://dx.doi.org/10.12688/wellcomeopenres.13828.2
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      Amendments from Version 1
We thank the reviewers for their positive and insightful comments. 
In the latest revision to the manuscript, in response to reviewer 
comments, we expand our discussion of the relationship between 
aneuploidy and gene expression to better reflect the complexities 
of the mechanisms controlling NLGN4X expression.
See referee reports
REVISED
Introduction
Developmental language disorder (DLD), a condition in which 
there are unexplained and persistent difficulties with language 
acquisition, affects around 7% of children (Norbury et al., 2016). 
Family studies show that DLD runs in families (Bishop, 2008), 
yet it has proved hard to identify any genetic or environmental 
factors that substantially increase risk. One reason is that DLD 
appears to be a complex multifactorial disorder where influ-
ences of individual genetic variants (alleles) are typically of 
small effect and may interact with other genetic factors and 
with the environment. Indeed, the ways in which disorders 
pattern in families suggest that common genetic variants that 
confer risk of language disorder may lead to an autistic phenotype 
when they occur with other genetic risk factors (Bishop, 2010). 
Thus the specific phenotype can depend on the constellation 
of genetic variants, rather than there being separate risk factors 
for DLD and autism spectrum disorder (ASD).
Rather than recruiting increasingly large numbers to try to find 
reliable associations between language disorders and genetic 
variants in genome-wide studies, one way forward is to study 
rare disorders that have a large impact on the phenotype, which 
may point to functional pathways involved in more common 
forms of disorder. One instance of a striking association between 
a genetic condition and language disorder in children of nor-
mal intelligence is provided by the sex chromosome trisomies 
(SCTs), each of which affects 1–1.5 per 1000 children (Nielsen 
& Wohlert, 1991). In the 1960s, research was initiated to inves-
tigate neurodevelopmental outcomes of children with SCT 
detected on neonatal screening. A systematic review of these 
studies showed that in all three trisomies there were high rates 
of speech and language impairment, motor problems, and educa-
tional difficulties, despite IQ being within normal limits in most 
cases (Leggett et al., 2010). Furthermore, studies of samples 
who have developmental language disorder of unknown cause 
find an increased prevalence of sex chromosome trisomies 
(Simpson et al., 2014).
In a study of children with sex chromosome trisomies identi-
fied on prenatal screening, Bishop et al. (2011) found that 7 of 
30 (24%) girls with karyotype 47,XXX, 9 of 19 (47%) boys 
with 47, XXY and 15 of 21 (71%) boys with 47,XYY had a 
history of speech and language-therapy, compared with rates of 
4% in sisters and 18% in brothers. Furthermore, this same study 
found that 2 of 19 (11%) boys with 47,XXY, and 4 of 21 (20%) 
boys with 47,XYY had received a diagnosis of ASD, compared 
with an estimated national prevalence rate of 0.2% in girls 
and 0.6% in boys. In addition, many children with SCTs who 
were not diagnosed with ASD had evidence of communication 
difficulties on parental report, including pragmatic (autistic-
like) problems, in all three karyotypes. More recent research has 
provided further evidence of a link with autism as well as other 
neurodevelopmental disorders in boys with a sex chromosome 
trisomy (Ross et al., 2012).
The impact of a trisomy is influenced by distinctive character-
istics of the sex chromosomes. In most cases, the phenotypic 
effects of SCTs are much less severe than the impact of an auto-
somal trisomy: Down syndrome (trisomy 21) usually leads to 
intellectual disability, and most other trisomies are lethal. Viable 
trisomies usually involve small chromosomes with a low gene 
count (for example the Y chromosome), where the effects asso-
ciated with altered gene dosage are less severe. An exception to 
this rule is the X chromosome. The X chromosome has a rela-
tively high gene count, but the impact of a duplication is relatively 
mild because mechanisms of inactivation have evolved, such that 
in typical females, only one copy is active, and in effect, both 
males and females have one set of functional genes from this 
chromosome. In trisomies that involve the X chromosome, two 
copies are inactivated, largely negating the presence of addi-
tional genetic material. There are, however, exceptions to this 
rule, with between 12–20% genes escaping inactivation to some 
extent: These include genes in the pseudo-autosomal region, 
and other genes that have homologues on the Y chromosome 
(Carrel & Brown, 2017).
The fact that there is an increase in problems affecting speech, 
language and communication in all three sex chromosome 
trisomies suggests there is an adverse impact of an additional 
copy of a gene that is expressed and has homologous forms on 
the X and Y chromosomes. Neuroligin-4 (NLGN4)
 is a strong 
candidate for such a gene, for several reasons (Bishop et al., 
2011). First, NLGN4X, located on Xp22, at least partly escapes 
inactivation (Berletch et al., 2011). Second there is a homolo-
gous gene, NLGN4Y on the Y chromosome at Yq11.2. Third, 
neuroligins are expressed in brain, as well as other tested tissues 
(Abrahams & Geschwind, 2010; Jamain et al., 2003). Fourth, 
as reviewed by Cao & Tabuchi (2017), mutations of NLGN4 
have been linked to ASD (Jamain et al., 2003; Laumonnier 
et al., 2004; Lawson-Yuen et al., 2008; Marshall et al., 2008; 
Pampanos et al., 2009; Talebizadeh et al., 2006; Yan et al., 
2008) – although this finding is inconsistent and other studies 
have not found autism in those with mutations of NLGN4 
(Chocholska et al., 2006; Macarov et al., 2007), or have failed 
to find abnormalities of NLGN4 in those with autism (Blasi 
et al., 2006; Gauthier et al., 2005; Liu et al., 2013; Vincent 
et al., 2004; Yanagi et al., 2012). Fifth, neuroligins are post-
synaptic transmembrane proteins that mediate development 
of functional synapses between neurons and are in the same 
functional network as neurexins (Craig & Kang, 2007), which 
have also been implicated in both DLD and ASD (Vernes et al., 
2008). Jamain et al. (2003) proposed that a defect in NLGN4 
may abolish formation or function of synapses involved in 
communication. Note that these authors also implicated another 
X-chromosome neuroligin, NLGN3, in autism, but this is 
located at Xq13, where one copy would be inactivated, and 
there is no homologue on the Y-chromosome. Therefore, unlike 
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NLGN4, NLGN3 would not be over-expressed in those with an 
extra X or Y chromosome.
For the reasons described above, we may hypothesise that an 
extra copy of NLGN4 could be implicated in neurodevelop-
mental problems. However, we also need to explain within- 
karyotype variation. Although there is a substantial increase in 
rates of speech, language and social communication problems in 
children with SCTs, the additional chromosome does not cause 
language impairment or ASD in a deterministic fashion. A minor-
ity of children have no evidence of developmental difficulties, a 
minority are severely affected with disabilities extending across 
many domains, and most have mild to moderate impairments 
(Linden & Bender, 2002).
The wide variation in outcomes suggests that the extra gene dos-
age could act as a multiplier of other risk factors, which interact 
with the sex chromosome genes in a dosage-dependent man-
ner and so only assume importance in the subset of individuals 
who have other genetic or environmental risk factors (Bishop & 
Scerif, 2011). This explanation is consistent with rodent research 
comparing the effect of a NLGN3 mutation between differ-
ent strains of mouse, suggesting the impact is dependent on the 
genetic background (Jaramillo et al., 2018). It also is compat-
ible with evidence from studies of mutations in NLGN4 in 
humans, which found that the same mutation may be asso-
ciated with different phenotypes within one family (Jamain 
et al., 2003; Laumonnier et al., 2004; Lawson-Yuen et al., 2008; 
Yan et al., 2005). As well as autism, NLGN4 associations have 
been described with intellectual disability, language disorder and 
Tourette syndrome (Lawson-Yuen et al., 2008; Yan et al., 2005).
Hypothesis
Our pre-planned analysis was designed to test the ‘double hit’ 
hypothesis
The ‘double hit’ hypothesis: Neuroligins act as a multiplier 
of effects of neurexins
The notion of a ‘double hit’ aetiology has been proposed 
previously to account for cases where a microdeletion is 
inconsistently associated with neurodevelopmental disorder 
(Girirajan et al., 2010; Newbury et al., 2013): the idea is that 
a severe phenotype may be seen when there are two copy 
number variants or mutations, each of which may be rela-
tively innocuous on its own. Here, we extend that idea to argue 
that the effect of altered neuroligin gene dosage may depend 
on the genetic background provided by autosomes (Bishop 
& Scerif, 2011). In this regard, it is of particular interest to 
note that neuroligin proteins form part of the same functional 
network as a group of presynaptic transmembrane proteins, 
known as neurexins; their interactions play a key role in synap-
togenesis (Hussain & Sheng, 2005). CNTNAP2 encodes a mem-
ber of the neurexin superfamily whose polymorphisms have 
been associated with common forms of language impairment 
(Graham & Fisher, 2015), though the effect size is relatively 
small (Vernes et al., 2008). The role of the CNTNAP2 protein in 
developing brain is not fully understood, and it is likely to play 
multiple roles at different time-points. While early functional 
studies of the CNTNAP2 protein indicated that it localises to 
nodes of Ranvier in axonal membranes, it is now recognised 
to have key functions at the synapse (Lu et al., 2016; Zweier 
et al., 2009). This raises the possibility that a CNTNAP2 
gene variant that has a modest effect in individuals of normal 
karyotype might have a much larger impact in the context of 
overexpression of a neuroligin. This hypothesis predicts that 
presence of an additional sex chromosome will amplify the 
impact of common genetic variants that have two character-
istics: (a) they have been associated with DLD or ASD, and (b) 
they are in the same functional network as neuroligins. Figure 1 
is a schematic showing two genes of interest to our current 
study, CNTNAPs and Neurexins, interacting with neuroligins 
in the synaptic cleft.
Methods
We report how we determined our sample size, all data 
exclusions, all manipulations, and all measures in the study 
(Simmons et al., 2012).
Power analysis and impact of ascertainment bias
We aimed to recruit sufficient children with trisomies to detect 
an effect size of d = 0.5 for each copy of a given genetic vari-
ant on a phenotype, equivalent to a standardized regression 
slope of 0.25. The anticipated effect size is hard to judge, but 
the average impact of a sex chromosome trisomy on verbal IQ 
is more than one SD from the general population mean (Leggett 
et al., 2010), suggesting that if the trisomy acts as a multiplier 
Figure 1. Neurexins (such as NRXN1), neuroligins (such as 
NLGN4) and contactin-associated proteins (such as CNTNAP2) 
all form part of the synaptic scaffolding system.
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of effects of autosomal variants, this effect could be large. 
When testing variants with a prior association with disorder, we 
can make a directional prediction. We aimed to recruit 150 
children with trisomies, which would have given 94% power 
to detect a slope of 0.25 on one-tailed test. However, we 
recruited only 140 children and had missing data on some vari-
ables, so numbers, and consequently power, are lower than this. 
In addition, we have to take into account that the sample is not 
representative of children with sex chromosome trisomies, 
because around 50% had the trisomy discovered in childhood 
when developmental difficulties were being investigated (see 
below). We devised a simulation to check the impact of these 
factors on power (see Appendix 1). This showed that a combina-
tion of N = 130 with 50% postnatally identified (and presumably 
biased) cases with mean phenotype score 0.9 SD below the 
group average (computed from a language factor score), reduced 
power to 87% on one-tailed test.
Participants
Sex chromosome trisomies: After excluding children with 
missing or inadequate DNA, participants included 42 girls 
with trisomy X, 43 boys with Klinefelter syndrome, and 45 
boys with XYY. These were combined in a single group of 130 
children for analysis, but are shown broken down by trisomy 
and background in Figure 2. Cases were recruited from National 
Health Service Clinical Genetics Centres, from two support 
groups (Unique: the Rare Chromosome Support Group, and the 
Klinefelter Syndrome Association), or from self-referral via 
advertisements on the OSCCI website and our Facebook page. 
A criterion for inclusion was that the child was aware of their 
trisomy status. In a previous study (Bishop et al., 2011) we noted 
that levels of impairment tended to be lower in cases where the 
trisomy was discovered on prenatal screening than in those 
identified later in childhood. We therefore asked parents spe-
cifically about the reason for genetic testing; for 59 children 
aneuoploidy only came to light because of behavioural or 
developmental problems. Note that this means that data from 
this sample should not be used to estimate prevalence of 
neurodevelopmental disorders in sex chromosome trisomies.
Comparison group: Comparison data came from a sample of 
children aged from 6 years 0 months to 11 years 11 months 
who had completed the same test battery, who were taking part 
in a twin study of language and laterality (Wilson & Bishop, 
2018a), and whose first language at home was English. Although 
twinning is a risk factor for early language delay, this effect 
appears to wash out with age, and by school age, genetic factors 
play a major role in the aetiology of language disorder (Bishop, 
2006; Rice et al., 2018). In this sample, we aimed for an over- 
representation of twin pairs in which one or both twins had lan-
guage or literacy problems that might be indicative of DLD. 
This was coded on the basis of parental response on a telephone 
interview: any mention of language delay, history of speech 
and language therapy, current language problems or dyslexia 
was coded as ‘parental concern’. We aimed to recruit 180 pairs 
selected on the basis of having language or literacy problems 
(60 MZ, 60 DZ opposite sex and 60 DZ same sex), and 60 unse-
lected pairs (20 of each type): we fell short of this goal as seen in 
Figure 3. For the current analysis, we grouped together all twins, 
regardless of zygosity and parental concern, and then divided 
them into two subsamples by selecting one twin from each 
pair at random, after excluding 18 cases with missing or insuf-
ficient DNA. This means we can replicate the analysis for twins 
with a diploid (typical) karyotype. Note that this replication 
Figure 2. Flowchart showing characteristics of children recruited to sex chromosome trisomies (SCT) group.
Reason for testing
Time of diagnosis
Excluded: DNA quality
Medical
Prenatal: N = 49
Postnatal: N =34
Neurodevelopmental
disorder
Postnatal: N = 59
N = 4
Trisomy
XXX
N = 31
XXY
N = 25
XXY
N = 18
XYY
N = 23
XYY
N = 22
XXX
N = 11
N = 8
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sample is not independent, as the genotype for the MZ twins 
is the same in the two subsamples, and is related for DZ 
twins.
Information about zygosity, gender and parental concern is 
shown for information, but was not used in the analysis. Because 
twins are not independent, the final sample was divided into 
two subgroups of 184 and 186 children respectively, each 
containing one member from each pair, selected at random. (Ns 
not equal because some twins had missing DNA from just one 
member of the pair).
Some twin children had evidence of autism spectrum disorder 
(N = 15) or intellectual disability (N = 3), and twelve failed a 
hearing screen on the day of testing, although none of them had 
any known sensorineural hearing loss. For the current study, 
because we were interested in a broader phenotype than pure 
DLD, these cases were retained in the sample.
Test battery
Psychiatric evaluation. In an initial telephone interview, parents 
were asked about the child’s medical and educational history, 
including a question about whether anyone had diagnosed the 
child with a neurodevelopmental disorder such as ASD, devel-
opmental language disorder (DLD) or specific language impair-
ment, dyslexia or dyspraxia. In addition, one or both parents 
were asked to complete the online Development and Wellbe-
ing Assessment (DAWBA) (Goodman et al., 2000) in their 
own time. 84 parents of SCT cases and 133 parents of twins 
complied with this request. The DAWBA gives information 
on likelihood of the child meeting criteria for a range of psy-
chiatric diagnoses; a final diagnosis is made by a trained rater 
who assimilates all the information and evaluates it against 
DSM5 criteria (American Psychiatric Association, 2013).
Language, literacy and cognitive assessments. All children were 
seen at home or in a quiet space in their school for a neurocog-
nitive assessment, using the battery of language and nonverbal 
ability tests shown in Table 1. Hearing was screened in left and 
right ears using a DSP Pure Tone Audiometer (Micro Audio-
metric Corporation). The child was familiarised with the task 
of raising their hand on hearing a tone using 40 dB (HL) tones. 
They were then tested with 25 dB pure tones at frequencies of 
500, 1000, 2000 and 4000 Hz. Louder tones were presented in 
5 dB steps to establish a threshold at any frequency where a 
25 dB tone was not detected. Children with an average thresh-
old greater than 30 dB in the better ear were categorized as 
failing the screen. The battery also included tests of literacy: the 
Picture and Digit naming tests from the Phonological Assess-
ment Battery (Frederickson et al., 1997), the Test of Word 
Reading Efficiency (Torgesen et al., 1999) and the Neale 
Analysis of Reading Ability -2 (Neale, 1999), but these are 
not included in the current analysis as there was much missing 
data from the youngest children. In addition, handedness 
and language laterality were assessed. Results from laterality 
assessments were unremarkable and are not considered further 
here (Wilson & Bishop, 2018a; Wilson & Bishop, 2018b).
Phenotypes
We considered three quantitative phenotypes ranging from 
a specific measure of a heritable language skill, through a 
Parental concern re language:
Exclude: No DNA
Total N twin children
Neither twin:
N = 53 pairs
One or both
twins:
N = 141 pairs
N children = 2 N children = 16
MZ:
N = 14 boys
44 girls
DZ:
N = 19 boys
27 girls
MZ:
N = 79 boys
45 girls
DZ:
N = 77 boys
65 girls
Figure 3. Flowchart showing characteristics of children recruited to comparison groups.
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more general language measure, to a measure that potentially 
indexes a wide range of neurodevelopmental problems:
A) Nonword repetition, which is regarded as a measure 
of phonological short-term memory. This was singled 
out as an individual measure because it has previously been 
identified in twin studies as a good marker of heritable lan-
guage problems (Bishop et al., 1996) and has also been 
associated with genetic variants linked to language/literacy 
in the CNTNAP2, CMIP, ATP2C2, KIAA0319, and 
DCDC2 genes (Carrion-Castillo et al., 2017; Marino et al., 
2012; Newbury et al., 2009; Newbury et al., 2011; Scerri 
et al., 2011; Vernes et al., 2008). In the current study, 
we used scaled scores from Repetition of Nonsense 
Words from the NEPSY (Korkman et al., 1998).
B) A general language factor derived from the four 
other language tests (Verbal Comprehension, Oromo-
tor Sequences, Sentence Repetition and Vocabulary). As 
documented in Appendix 3, the decision to combine these 
measures into a single language factor was made after 
exploring the factor structure of the available phenotypic 
measures, with the goal of obtaining a reliable indicator 
of overall language function.
C) A global measure of burden of neurodevelopmental 
problems extending beyond language, including autistic 
features. This was developed on an ad hoc basis, using all 
available information from parental report (see 
Appendix 4).
DNA collection and analysis
Oragene kits (OG-500, DNA Genotek Inc, Ontario, Canada) 
were used to collect saliva for DNA analysis from children with 
SCTs and their parents and available twin pairs. DNA extrac-
tion was performed using an ethanol precipitation protocol as 
detailed in the standard protocol (DNA genotek). All extracted 
DNA was genotyped on the Infinium ‘Global Screening Array-24 
(v1)’, which includes 692,824 SNPs including rare and common 
variations. Data were processed in the Illumina BeadStudio/
GenomeStudio software (v. 2.03) and all SNPs with a Gen-
Train (quality) score of < 0.5 were excluded at this stage. All 
genotypes were further filtered using PLINK software v1.07 
(Purcell et al., 2007); as recommended by Anderson et al. 
(2010), samples with a genotype success rate below 95% 
or a heterozygosity rate ±2 SD from the mean were removed, as 
were SNPs with a Hardy-Weinberg equilibrium P < 0.000001 
or a minor allele frequency of less than 1%. Identity data 
within families and twin-pairs were used to exclude samples 
with unexpected gender or relationships. SNPs that showed 
an inheritance error rate > 1% or skewed missing rates between 
genotype plates were also excluded. Control data (CEU, YRI, 
CHB, JPT, Hapmap release #3) were employed through a 
principal component analysis within Eigenstrat (Price et al., 
2006) to identify individuals with divergent ancestry. Sixteen 
individuals (6 twin pairs and 4 SCT cases) were identified as hav-
ing African ancestry and 21 individuals (6 twin pairs and nine 
SCT family members) were identified as having Asian ances-
try. Any SNPs that showed a significant association with non- 
European ancestry (P < 0.0001) were excluded. The final 
genome-wide dataset consisted of 500 individuals (370 twins, 
divided into two subgroups, and 130 independent SCT cases) 
and 451,093 autosomal SNPs with a genotyping rate of 99.78%.
Procedure
Ethical approval was obtained for the study in 2011 from 
the Berkshire NHS Research Ethics Committee (reference 
11/SC/0096), and data collection started in August of that year, 
finishing in October 2016. Information sheets, consent forms 
and ethics approval documents are available on Open Science 
Framework. Families who had expressed interest in the study 
were interviewed by telephone to assess whether the child met 
inclusion criteria, and if so, an appointment was made to see the 
child at home or at school, depending on parental preference. 
Families were widely dispersed around the UK, including 
Northern Ireland, Scotland, Wales and England. During the 
course of recruitment a total of eight research assistants as well 
as the senior author were involved in assessing children. The 
Table 1. Assessment battery.
Instrument Measure
Woodcock Johnson III Tests of Cognitive Abilities (Woodcock et al., 2007) Verbal Comprehension
NEPSY: A Developmental Neuropsychological Assessment (Korkman et al., 1998) Repetition of Nonsense Words
Oromotor Sequences
Sentence Repetition
Wechsler Abbreviated Scale of Intelligence (WASI) (Wechsler, 1999) Vocabulary
Block Design
Matrices
Parental questionnaires 
The Children’s Communication Checklist-2 (CCC-2) (Bishop, 2003)
The Social Responsiveness Scale (SRS) (Constantino, 2005)
For the NEPSY tests, norms extend only to age 12 yr 11 months, and so we used extrapolated scores, as documented in 
Appendix 2.
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assessment was conducted in a single session lasting between 
2–3 hours per child, with breaks where needed.
Analysis plan
Study data were analysed using R software (R Core Team, 
2016), with the main database managed using REDCap 
electronic data capture tools hosted at the University of Oxford 
(Harris et al., 2009).
Potentially, there is a very large number of genotypes and 
phenotypes that could be analysed to test our hypothesis, as 
well as different ways of creating subgroups. This considera-
tion, coupled with the small sample size, makes it important to 
control adequately for multiple testing to guard against type I 
error (Grabitz et al., 2018). For this reason, we stored pheno-
type and genotype data separately and specified an analysis plan 
in detail, as reported in our stage 1 registered report (Newbury 
et al., 2018). The analysis of genotype-phenotype associations 
was conducted after this plan had been registered and 
peer-reviewed.
Subgroups
In our main pre-specified analysis we treated all three 
trisomies together. This is because the double hit hypothesis 
postulates a common mechanism that would apply regardless of 
karyotype. We specified that if we found an association between 
genotype and phenotype, we would carry out exploratory analy-
ses to consider whether this is moderated by karyotype. This 
would allow us to test a prediction by Skuse (2018) that there 
is more variable expressivity of NLGN4X than NLGN4Y, 
which should lead to lower phenotypic variability in XYY 
compared to the other karyotypes. Note, however, that the 
ascertainment bias in the sample is problematic for making 
cross-karyotype comparisons, and the focus would have to be 
just on those who were not diagnosed because of neurodevel-
opmental problems (see Figure 2). This is a small sample and 
so there would be a high risk of missing a true effect (type II 
error).
Prioritising genotypes for analysis
We conducted a series of literature searches to prioritise 
autosomal genes for analysis, focusing on genes that had an 
association with childhood speech and language disorders and 
that were relevant for synaptic function (see Appendix 5). This 
led us to select two candidates; CNTNAP2 and NRXN1. Both of 
these genes are large (>1 MB) and included over 100 SNPs from 
the genotyping array. In order to avoid false positives with our 
small sample size, we chose to focus our analysis on regions 
that have previously been associated with neurodevelopmental 
disorder, analysing all genotyped SNPs (after quality control 
steps described above (see “DNA collection and analysis”) within 
these selected regions.
In CNTNAP2 (NM_014141), we focused on a region span-
ning exons 13–14 (chr7:147,514,390-147,612,852 (hg19)). 
This region includes a cluster of 9 SNPs previously associ-
ated with language disorder (Vernes et al., 2008; Whitehouse 
et al., 2011). We had direct genotype data for 22 SNPs across 
this region. In addition, we used imputation to obtain genotypes 
for SNPs rs2710102 and rs7794745. These were the first SNPs 
reported to be associated with ASD, and represent the two main 
SNPs used in the majority of association studies in neurode-
velopmental disorders (Alarcón et al., 2008; Arking et al., 
2008). These two SNPs were not directly genotyped on the 
Illumina arrays and were therefore imputed for all individu-
als. Imputation was performed on the Michigan Imputation 
Server, an online server which generates phased and imputed 
genotypes using high-density reference panels. Variant Call 
Files (VCF) were uploaded for 15,936 SNPs genotyped on 
chromosome 7. Genotypes were phased within Eagle and 
imputed by Minimac against the Human Reference Panel 
hrc.r1.1.2016, which includes 64,940 haplotypes of predomi-
nantly European ancestry. In total, genotypes were generated 
for 2,289,829 SNPs across chromosome 7, 513,970 of which 
had quality scores 0.9. The two SNPs of interest, rs2710102 and 
rs7794745 had quality scores of 0.9938 and 0.94127 respectively.
The second candidate is NRXN1 (NM_004801). Although 
this gene met our criteria of being relevant for both synaptic 
function and neurodevelopmental phenotypes, the studies 
showing this link involved deletions rather than common vari-
ants (Ching et al., 2010). A recent analysis of clinical micro-
array data showed that deletions in exons near the 5′ end of 
NRXN1 were specifically implicated in neurodevelopmental 
disorders (Lowther et al., 2017). Accordingly, we focused on 
23 SNPs in this region of the gene chr2:51,141,501-51,280,121 
(hg19). These SNPs covered exons 1–4 plus 20 Kb upstream 
(5’) of the gene as this region includes important regulatory 
sequences. Details of the SNPs included in the analysis are shown 
in Appendices 6 and 7.
The SNPs within the chosen regions were filtered for minor 
allele frequency and Hardy Weinberg Equilibrium (as out-
lined in DNA collection and analysis) but were not pruned for 
linkage disequilibrium. Previous simulations indicate that the 
Generalized Structured Component Analysis (GSCA) method 
is not greatly affected by linkage disequilibrium (see Romdhani 
et al., 2014). Across the CNTNAP2 region, six pairwise 
combinations of SNPs had R2 > 0.8. Across the NRXN1 region, 
8 pairwise combinations of SNPs had R2 > 0.8. Details of 
the SNPs included in the analysis and a table of correlations 
between SNPs are shown in Appendix 8.
Statistical methods
CNTNAP2 and NRXN1 genes from the trisomy sample were 
analysed for association with a latent variable based on the 
three phenotypes using a structural equation modelling (SEM) 
approach adapted for genetic analysis (Romdhani et al., 2015). 
The model specification for our analysis is shown in Figure 4.
The GSCA analysis estimates the path from each gene to the 
Neurodev factor, with significance calculated by permutation 
analysis.
Romdhani et al. (2015) used the GSCA developed by Hwang & 
Takane (2004). This method uses component-based path 
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modelling rather than traditional covariance-based SEM, allowing 
adequate model fit to be achieved when using smaller samples 
(Chin & Newstead, 1999; Tenenhaus et al., 2005). The meas-
urement models in the SEM framework are not typical 
regression format using latent factors; instead they are fitted 
using alternating least squares to estimate the weights and param-
eters, which is similar to principal components analysis. The 
advantage of this approach is that it does not attempt to fit the 
whole covariance matrix for observed and latent variables, but 
rather fits a separate measurement model for the contribution 
of observed variables to each latent factor, as well as a covari-
ance model for the latent factors. Hence, we do not estimate the 
contribution of individual SNPs in each gene to the phenotype; 
rather, their influence is represented via the weighted sum. 
Similarly, the latent phenotypic factor (termed Neurodev 
factor in Figure 4) is a weighted sum of the three measures 
of the phenotype. We estimated the significance of one direct 
pathway from the CNTNAP2 gene to the latent phenotype, and 
one from NRXN1 to the latent phenotype. This method thus 
gives a single estimate of the overall impact of SNPs in a region of 
the phenotype.
We conducted simulations that indicated that this method is fea-
sible with the number of SNPs and phenotypes in our sample 
(see Appendix 1): the permutation method, used by this approach 
to effectively quantify the test statistic distribution, generates 
p-values independently for each path, and a correction is 
required to take this into account. Because the evidence of 
association of common variants was stronger for CNTNAP2 
than for NRXN1, we used a sequential approach to setting a 
significance level (alpha), using a critical p-value of .05 to test 
the pathway from CNTNAP2 to the Neuro factor, and .025 for the 
pathway from NRXN1 to the Neuro factor.
In addition, we conducted the same analyses with children from 
the two comparison samples.
We predicted that one or both paths from CNTNAP2 and 
NRXN1 to the Neurodev factor would indicate significant 
association in the sex chromosome trisomy sample. We further 
predicted that any associations in the comparison samples will 
be similar in direction, but smaller in size and may not reach 
statistical significance.
Results
Figure 5 shows the distributions of scores on the three pheno-
types for children with sex chromosome trisomies and the two 
comparison groups. The scores for Global burden are inverted 
so a low score corresponds to impairment, to be consistent with 
the other two measures, and scores on Global burden and Non-
word repetition are jittered vertically as well as horizontally for 
clarity. Phenotypic characteristics of children with SCTs will 
Figure 4. Structural equation diagram for analysis.
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be the focus of a separate publication, but we may note that, as 
anticipated, the group with SCTs show evidence of impairment on 
all three phenotype measures, but with a wide range of scores. 
For the combined sample with all cases (N = 500), nonword 
repetition correlated 0.76 with the language factor, and 0.60 
with the global impairment rating. The language factor and 
global impairment rating correlated 0.69.
GSCA path-fitting analysis
Data from the three phenotypes were fitted using the model 
in Figure 4, first for the SCT group, and then separately for 
the two comparison groups. Table 2 shows the p-values based 
on 5000 permutations. The association with the ‘Neurodev’ 
factor did not meet our criterion for significance for either 
NRXN1 nor CNTNAP2 (see Table 2).
Additional exploratory analyses
Further exploratory analyses were conducted to rule out the 
possibility that our analytic approach may have missed 
significant associations with specific SNPs. Appendix 9 shows 
associations computed for all the individual SNPs entered into 
the analysis, as well as the regression slopes relating number of 
minor alleles to phenotype for the two SNPs in CNTNAP2 that 
have been a particular focus of research attention. The distri-
bution of p-values seen for the whole collection of SNPs did 
not differ from that expected by chance.
In addition, we followed up suggestions by Skuse (2018) that 
results may vary by karyotype, because the expression of the 
X-linked homologue (NLGN4X) is variable, whereas in males 
with XYY, NLGN4Y is fully expressed. Accordingly, one 
might expect a more severe impact of a double hit in the XYY 
group. To test this, we reran the GSCA separately for XXX, 
XXY and XYY subsamples, restricting consideration to those 
who were diagnosed prenatally, as specified in our protocol. 
As shown in Table 3, there was no hint of any association 
Figure 5. Pirate plots (Phillips, 2017) for sex chromosome trisomies (SCT) and two twin groups, showing individual cases as points, 
with bold line depicting median, for Nonword repetition (scaled score), Language factor and Global neurodevelopmental impairment 
(inverted so low score reflects impairment).
between genotype and phenotype in these subgroups. Note, 
however, as we originally stated, this analysis has very low 
power to detect true effects.
Table 2. P-values from 5000 
permutations for association 
with neurodevelopmental 
factor for NRXN1 and 
CNTNAP2: results from 
Generalized Structured 
Component Analysis (GSCA).
Group NRXN1 CNTNAP2
SCT 0.703 0.268
Twin1 0.080 0.323
Twin2 0.162 0.524
Table 3. P-values based on 5000 
permutations for association 
with neurodevelopmental factor 
for NRXN1 and CNTNAP2 for sex 
chromosome trisomies (SCT) 
cases subdivided by karyotype, 
excluding those identified 
because of neurodevelopmental 
problems: results from 
Generalized Structured 
Component Analysis (GSCA).
Group NRXN1 CNTNAP2
XXX, N = 31 0.311 0.256
XXY, N = 25 0.341 0.076
XYY, N = 23 0.787 0.447
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Discussion and conclusions
We assessed a “double-hit” model of differential susceptibility 
in children with sex-chromosome trisomies (SCTs), focus-
ing on the hypothesis that the effects of common variations in 
neuroligin/neurexin genes upon language development are 
amplified in children with a sex chromosome trisomy (Bishop 
et al., 2011). This hypothesis was evaluated through a targeted 
analysis of two genes in the neuroligin/neurexin pathway, CNT-
NAP2 and NRXN1, both of which have previously been asso-
ciated with language development. A set of 47 SNPs were 
divided into corresponding candidate genes forming latent fac-
tors (weighted sums, in this case). These were analysed in rela-
tion to neurodevelopmental outcomes in a cohort of children with 
sex chromosome trisomies and two comparison twin groups, 
within a generalised structured component model (Hwang & 
Takane, 2004). Outcomes were represented by three related latent 
phenotype factors; non-word repetition, a measure of phono-
logical short-term memory that has previously been associ-
ated with genetic variants associated with language and/or 
literacy, a general language factor score, and a measure of global 
neurodevelopmental impairment.
Children with SCTs showed evidence of impairment across all 
three of these phenotypes, indicating that they represent sensitive 
markers of the difficulties encountered by children with SCTs, 
and there was a wide range of severity of impairment. However, 
a factor derived from the three phenotypes was not associ-
ated with either candidate gene within the SCT sample or the 
two comparison datasets. Permutation testing confirmed that 
no effects reached our specified level of significance.
To address a concern that our method may mask associations 
with specific SNPs, we conducted an exploratory investigation 
of the individual variants within NRXN1 and CNTNAP2 (see 
Figure 4) using a more conventional regression approach test-
ing for association with each of the three outcome factors 
(Appendix 9). The distribution of p-values across SNPs within 
each of the groups, aligned with that expected by chance, tak-
ing into account the correlations within the SNP set and the 
correlations between phenotypes.
Figure 6 shows results for two variants in CNTNAP2 that had 
previously been robustly associated with language (rs779475 
and rs207102). Previous studies indicate that for both of these 
SNPs the minor allele (T allele for rs779475 and G allele for 
rs207102) was associated with poorer neurodevelopmental 
outcomes (Alarcón et al., 2008; Vernes et al., 2008; Whitehouse 
et al., 2011). However, in the current study, the direction of 
effects fluctuated between sample groups and outcome meas-
ures for both SNPs (see also Appendix 9) and did not approach 
statistical significance.
Lack of association
Considering first the failure to replicate associations between 
specific SNPs and phenotypes in the twin comparison samples, 
we should not be surprised by this result. Non-replication is 
common in genetic association studies and primarily reflects 
the complexity of the underlying genetic effects (Hirschhorn 
et al., 2002; Ott, 2004). The majority of genetic contributions to 
language development are reported to have small effect sizes 
and are characteristically heterogeneous (Newbury et al., 
2014). Our sample size gave limited power to detect the kinds 
of effect size obtained in previous studies.
For the SCT sample, we argued that effect sizes would be larger 
if the double hit hypothesis was correct. However, it was still 
the case that unless we took steps to maximise the chances 
of association and to guard against type I errors we were at 
risk of obtaining spurious results (Grabitz et al., 2018). This 
meant that we had to decide in advance which genes to focus 
on: it is entirely possible that a different selection of SNPs 
might have provided evidence for the double hit hypothesis: 
the challenge for this study was how to determine the optimal 
strategy for analysis. We used a structured literature review to 
Figure 6. Mean scores for three phenotypes for SCT and both twin groups, in relation to number of minor alleles for rs2710102(G) 
and rs7794745(T).
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identify genes implicated in developmental language disorder, 
generating a list of 41 candidate genes. Publication data 
for these genes were further scrutinised to narrow our search 
to a small number of genes with consistent and robust evi-
dence for association. In this stage, we focused upon functional 
and behavioural dimensions of synaptic function and speech, 
language and communication respectively. Two genes scored 
highly on both of these dimensions and were selected for 
further literature-based review. One hundred and seven papers 
referring to CNTNAP2 were examined. Of these, 32 included an 
analysis of common genetic variants and 19 examined rare vari-
ants of putative function. These papers tended to focus upon 
autism spectrum disorders but also considered speech and 
language and a diverse range of neurodevelopmental outcomes 
including intellectual disability and schizophrenia. Of the 32 
common variant papers, 27 (84%) reported positive association, 
primarily with SNPs rs2710102 and/or rs7794745. The CNT-
NAP2 gene has been implicated by both genome-wide screening 
approaches and targeted replication investigations and is reported 
to have a moderate effect size upon neurodevelopmental out-
comes (Vernes et al., 2008). One hundred and thirty one NRXN1 
papers were examined, including 45 reporting rare variants 
and 20 investigating common variants. For the NRXN1 gene, 
there was a clear focus upon the relevance of copy number vari-
ants (deletions and duplications) in autistic disorder, epilepsy 
and schizophrenia in the rare variant studies while investiga-
tions of common variants focused upon nicotine dependency and 
working memory. Interestingly, a recent analysis of clinical 
microarray data showed that deletions in exons near the 5´ end of 
NRXN1 were specifically implicated in neurodevelopmental 
disorders (Lowther et al., 2017). Given the large size of these 
two genes, we chose to focus our analysis on regions that have 
previously been associated with neurodevelopmental disorder, 
namely exons 13-14 in CNTNAP2 and the 5´ region of NRXN1. 
This evidence-based strategy reduced the possibility of false 
positives by providing a clear targeted rationale. However, it meant 
that our analyses were restricted to a small number of genetic 
variants within only two candidate genes. Within a complex 
genetic model, it is unlikely that one or two genes will explain 
a large proportion of the variance observed in language and 
communication, even under a hypothesis of increased 
susceptibility. Furthermore, our study design means that earlier 
identified candidates received more focus as they had a greater 
volume of supporting publications. We acknowledge that it 
is possible that we would have found association to alterna-
tive genes and/or SNPs if our search space had been extended 
but the chances of a type I error would also have increased 
(Grabitz et al., 2018). The publication of a pre-registered strat-
egy helped us to consider effect sizes and analysis strategies 
upfront, balancing out these considerations before the analysis 
stages.
Analysis methods
Genetic association studies typically consider each SNP as an 
independent variable giving rise to a particularly high number 
of tests. The typical significance threshold for a genome wide 
association study (GWAs) is 5×10-8 and a Bonferroni correc-
tion for the 47 SNPs and three factors tested in the current study 
stands at 0.00035. Such adjustments are largely considered to be 
overly conservative as they do not account for the relationships 
between variants or the increased density of available genetic 
information (Fadista et al., 2016). Recent developments have 
therefore been driven by gene-based analyses in which all 
variants within a gene are collapsed into a single factor for 
analysis. Gene-based methods reduce the number of tests required 
and can be applied to common and rare variants and allow for 
heterogeneous effects across a given gene (Lee et al., 2014). 
Many gene-based methods exist, but most make quite specific 
assumptions and different tests can provide optimal power 
depending on study design (Lee et al., 2014).
In this paper, we employed a gene-based analysis method 
which adapts a generalized structured component-based path 
model (GSCA) (Hwang & Takane, 2004) for genetic analy-
sis. Previous studies indicate that this method is sensitive within 
relatively small sample sizes and enables the consideration of 
multiple related variables within a small number of latent fac-
tors (Romdhani et al., 2015). Our own simulations (Appendix 1) 
indicated that this method was appropriate for a relatively 
small number of SNPs (<50) and traits, making it an attractive 
approach for a targeted hypothesis-led approach. Nonetheless, 
GSCA is a relatively novel approach to genetic analyses and the 
allowable number of variants remains small in genetic terms. 
More than 100 SNPs would be required to capture full informa-
tion regarding common genetic variation across CNTNAP2 and/or 
NRXN1 and this dataset would be too large to give reliable 
results with our sample size.
Other gene-based tests based upon alternative statistical methods 
(e.g. burden tests, variance components and weighted analyses) 
are available and these could equally have been applied 
within this study. It is possible that the use of these alterna-
tive statistics may have allowed the detection of association. 
Note however that, as a general rule, the number of participants 
should be significantly greater than the number of parameters 
measured. Gene-based methods collapse effects across SNPs 
reducing the number of parameters to be estimated; however, 
adequate sample size should be ensured and not based 
on reducing dimensionality of data to achieve satisfactory power.
Alternative models of effects
Our strategy focused upon common genetic variants within a 
small number of well-supported candidate genes but it is clear 
that language and communication are complex traits which 
involve many interacting loci with different functional effects. 
Many candidate genes have been identified and characterised in 
the context of severe neurodevelopmental disorders and large 
hit events (rare variants and/or copy number changes) and it is 
possible that the effects of a given risk variant may be affected 
by genetic background, the mechanism of mutation and 
environmental factors (Weiner et al., 2017). There are many 
possible mechanisms of functional interaction that would not be 
detected by the approach taken in this study. For example, variants 
which affect gene expression (eQTLs) typically occur outside of 
coding regions and can have long-range effects (GTEx 
Consortium et al., 2017). Since this study targeted restricted gene 
regions, we would not have detected long-range or trans- effects 
upon gene expression. Indeed, the control of gene expression 
is a complex process which involves many factors and this is 
complicated in this case by the involvement of X-inactivation 
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and aneuploidy. Thus it would be of interest to directly measure 
the expression of the NLGN4 genes and relate these to neurode-
velopmental outcomes. Although this approach would only offer 
a snapshot of gene expression in time and space, it would be 
one step closer to contributory mechanisms and would provide a 
picture of the effects of aneuploidy upon gene expression and 
vice versa. Similarly, while a SNP-based analysis may tag 
structural rearrangements (deletions and duplications), an alter-
native approach would be required to fully assess the role of 
copy number variants. Copy number variants have been reported 
to play a role in neurodevelopmental disorder (Girirajan et al., 
2011) and developmental language disorders (Simpson et al., 
2015).
In summary, we did not observe association to either the 
CNTNAP2 or NRXN1 genes in our SCT cases or comparison 
controls. We cannot reject the double-hit hypothesis on the basis 
of these analyses alone, but we can conclude that variants in the 
specific gene regions that we focused on do not appear to explain 
the phenotypic variation in neurodevelopment that is seen in 
children with an additional sex chromosome. In order to further 
the double hit hypothesis, additional analyses that consider a 
greater number of variants or candidate genes and/or differ-
ent functional mechanisms will be required. Any such analyses 
should be carefully controlled and pre-registered to avoid 
“fishing” experiments in what is inevitably a small sample.
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The Stage 2 report summarizes the findings of the proposed investigation, which aimed to test the
hypothesis that neuroligin genes on the sex chromosomes (specifically NLGN4X and Y) would be
expressed in excessive dosage in multiple sex chromosome trisomy (SCT) aneuploidies (XXX,XXY,XYY)
and that there could be an epistatic interaction between those genes and a specific autosomal gene on
Chromosome 7 (CNTNAP2), variants of which have been shown to be associated with disorders of
language in particular. Accordingly, this interaction would explain the deficits in language skills
characterizing SCTs, which are relatively more common in XYY than XXX individuals, with XXY males
intermediate between the other two conditions.
In the original proposal, besides the epistatic interaction with CNTNAP2, the authors also proposed an
interaction between NLGN and the autosomal gene NRXN1 (chromosome 2), such that variants in that
gene within putative regulatory regions could modify the impact of excessive NLGN expression.
Essentially, the purpose of the investigation was to evaluate an intriguing ‘double-hit’ mechanism,
whereby the variable impact of sex chromosome aneuploidy on language phenotypes would be explained
by some sort of interaction with autosomal genetic variation, in two specific candidates (CNTNAP2 and
NRXN1). The locus of the interaction was proposed to be at the synapse, reflected in variable synaptic
scaffolding with functional consequences. Underlying this hypothesis was the observation that there is a
transmembrane connection in the synaptic scaffolding system between CNTNAPs and
Contactins/Catenins and also between Neuroligins/Neurexins as illustrated in Figure 1.
Having reviewed the material in the original Stage 1 Proposal, I suggested there should be the most
variable language phenotypes within the XXX sample, and the least variable language phenotype in the
XYY sample. I expressed skepticism that the overall double-hit hypothesis would be supported by the
proposed analysis, and also that the novel statistical methods to be used would truly get around the
problem of limited power (which arose from the small sample size).
The Stage 2 report (19  July 2018) states there was wide phenotypic variation observed within the SCT
groups, but no overall association could be found with the variants that had been measured on the
autosomal genes CNTNAP2 or NXN1. Nor were there any specific associations within each of the
trisomies investigated. The latest report reiterates much of the information about the study design that
was provided by the Stage 1 report (and its April 2018 revision).
th
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 was provided by the Stage 1 report (and its April 2018 revision).
A variety of analyses are presented for which the overall structure is represented by Figure 4. It is
gratifying that measures of language impairment, for which details will be given in a future publication, did
show sensitivity to the presence of sex chromosome aneuploidy status, and good correlations with the
language factor. I was not surprised that the findings reported in Figure 6, which attempted to replicate
previous reports on associations between specific SNPs on CNTNAP2 and neurodevelopmental
impairment, showed no statistically significant result. As the authors state, replication in these complex
phenotype-genotype associations is the exception rather than the rule, and there is likely to be publication
bias in favor of positive results. It is commendable that the authors did not continue to look for association
with alternative genes/SNPs in a fishing expedition that would have led them open to the risk of a type 1
error.
There was no evidence found that the results varied by karyotype as I had proposed in my earlier
commentary, on the grounds that there was likely to be a more variable language phenotype in XXX than
XYY individuals because NLGN4X was subject to variable and partial X-inactivation (whereas NLGNY
was fully expressed). Accordingly, all males with XYY would over-express NLGN4Y to the same extent,
but females with XXX (in which two X-chromosomes are silenced) would express NLGN4X to a highly
variable degree depending on individual differences in X-inactivation status.
I was surprised by the comment that, in the context of a discussion about alternative models of effects,
that there are many possible mechanisms of functional interaction that would not be detected by the
approach taken by this study – such as functionally valid variants that lie outside the coding regions. My
understanding is that many SNPs employed in this study were indeed outside coding regions (though
may have had functional significance).
There is a further comment concerning a mechanism whereby there could be modulation of expression of
NLGN4X/Y by autosomal variants: a point made in my original commentary is that the regulation of
NLGN4X is complex in relation to X-inactivation, and that its expression in individuals with more than one
X chromosome is unpredictable for that reason in particular. This mechanism leading to variability of
expression may be more pertinent than modulation by autosomal genes.
Overall, the study was conducted with impeccable scientific rigor and exemplifies the benefits of
registering a research design with Wellcome Open Research, and seeking peer review before
undertaking the proposed analysis.
Are the data able to test the authors’ proposed hypotheses by satisfying the approved
outcome-neutral conditions (such as quality checks, positive controls)?
Yes
Are the introduction, rationale and stated hypotheses the same as the approved Stage 1
submission? (required)
Yes
Did the authors adhere precisely to the registered experimental procedures? If not, has an
explanation been provided regarding any change?
Yes
Are any unregistered post hoc analyses added by the authors justified, methodologically sound
and informative?
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 and informative?
Yes
Is the work clearly and accurately presented and does it cite the current literature?
Yes
Is the study design appropriate and is the work technically sound?
Yes
Are sufficient details of methods and analysis provided to allow replication by others?
Yes
If applicable, is the statistical analysis and its interpretation appropriate?
I cannot comment. A qualified statistician is required.
Are all the source data underlying the results available to ensure full reproducibility?
Yes
Are the conclusions drawn adequately supported by the results?
Yes
 No competing interests were disclosed.Competing Interests:
Reviewer Expertise: Neurodevelopmental disorders, sex chromosomal aneuploidies, genetic
syndromes associated with intellectual disability
I confirm that I have read this submission and believe that I have an appropriate level of
expertise to confirm that it is of an acceptable scientific standard.
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© 2018 Pourcain B. This is an open access peer review report distributed under the terms of the Creative Commons
, which permits unrestricted use, distribution, and reproduction in any medium, provided the originalAttribution Licence
work is properly cited.
   Beate St Pourcain
Language and Genetics Department, Max Planck Institute for Psycholinguistics, Nijmegen, The
Netherlands
In this Stage 2 Registered Report Newbury and colleagues studied whether the presence of an extra sex
chromosome is associated with an increased rate of neurodevelopmental difficulties involving language.
The authors investigate here a double-hit hypothesis, specifically that the presence of an additional sex
chromosome amplifies the impact of common autosomal genetic variants residing within genes involved
in synaptic functionality. The authors specifically focus on the functional network of neuroligins and study
common variants within CNTNAP2 and NRXN1, and use complex analysis strategies, such as
Generalised Structural Component Analysis, to overcome small sample size. Unfortunately, the sample
size was small, and the authors found no support for the idea that common variants in   or CNTNAP2
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 size was small, and the authors found no support for the idea that common variants in   or CNTNAP2
are associated with the severity of language and neurodevelopmental impairments that oftenNRXN1 
accompany an extra X or Y chromosome.
 
However, although this study was small, the authors could make suggestions, based on their extensive
expertise, how a future study should be conducted that may be able to overcome current limitations. It is
highly commendable that authors followed a fully transparent analysis approach, sharing scripts and
simulated comparable data. The authors may also want to highlight the transferability of their applied
structural equation modelling approach.
Are the data able to test the authors’ proposed hypotheses by satisfying the approved
outcome-neutral conditions (such as quality checks, positive controls)?
Yes.
Are the introduction, rationale and stated hypotheses the same as the approved Stage 1
submission? (required)
Yes.
Did the authors adhere precisely to the registered experimental procedures? If not, has an
explanation been provided regarding any change?
Yes.
Are any unregistered post hoc analyses added by the authors justified, methodologically sound
and informative?
Yes.
Is the work clearly and accurately presented and does it cite the current literature?
Yes
Is the study design appropriate and is the work technically sound?
Yes
Are sufficient details of methods and analysis provided to allow replication by others?
Yes
If applicable, is the statistical analysis and its interpretation appropriate?
Yes
Are all the source data underlying the results available to ensure full reproducibility?
Yes
Are the conclusions drawn adequately supported by the results?
Yes
 No competing interests were disclosed.Competing Interests:
I confirm that I have read this submission and believe that I have an appropriate level of
expertise to confirm that it is of an acceptable scientific standard.
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